DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 161 filers reported holding DEPOMED INC in Q4 2017. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $13,000 | -23.5% | 2,004 | -20.0% | 0.00% | – |
Q1 2018 | $17,000 | -15.0% | 2,504 | 0.0% | 0.00% | – |
Q4 2017 | $20,000 | -50.0% | 2,504 | -63.9% | 0.00% | – |
Q3 2017 | $40,000 | -4.8% | 6,938 | +77.7% | 0.00% | – |
Q2 2017 | $42,000 | +2.4% | 3,904 | +18.2% | 0.00% | – |
Q1 2017 | $41,000 | -99.5% | 3,304 | -99.3% | 0.00% | -100.0% |
Q4 2016 | $7,946,000 | +41.8% | 440,995 | +96.5% | 0.00% | +33.3% |
Q3 2016 | $5,605,000 | +13245.2% | 224,476 | +10235.0% | 0.00% | – |
Q2 2016 | $42,000 | -77.4% | 2,172 | -83.7% | 0.00% | – |
Q1 2016 | $186,000 | -18.1% | 13,301 | +6.2% | 0.00% | – |
Q4 2015 | $227,000 | +587.9% | 12,528 | +621.7% | 0.00% | – |
Q3 2015 | $33,000 | -74.6% | 1,736 | -71.4% | 0.00% | – |
Q2 2015 | $130,000 | +91.2% | 6,071 | +100.4% | 0.00% | – |
Q1 2015 | $68,000 | +2166.7% | 3,029 | +1601.7% | 0.00% | – |
Q4 2014 | $3,000 | -94.5% | 178 | -95.3% | 0.00% | – |
Q1 2014 | $55,000 | +5400.0% | 3,800 | +1809.5% | 0.00% | – |
Q2 2013 | $1,000 | – | 199 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DELTEC ASSET MANAGEMENT LLC | 2,252,402 | $31,376,000 | 7.88% |
Healthcare Value Capital, LLC | 350,000 | $4,876,000 | 7.16% |
Senvest Management, LLC | 4,977,256 | $69,333,000 | 5.82% |
Consonance Capital Management LP | 2,756,360 | $38,396,000 | 5.81% |
Opaleye Management Inc. | 325,000 | $4,527,000 | 2.82% |
Krensavage Asset Management, LLC | 447,000 | $6,227,000 | 2.23% |
Healthcare Value Capital, LLC | 100,000 | $1,393,000 | 2.05% |
Starboard Value LP | 2,950,000 | $41,094,000 | 1.44% |
HealthInvest Partners AB | 200,000 | $2,786,000 | 1.30% |
OAK RIDGE INVESTMENTS LLC | 7,206,286 | $100,384,000 | 1.29% |